EUVIMEDSkopri EUVIMED
BeobachtungsstudieKohortenstudieStudienprotokollOpen access

Safety of Administration of Vasopressors Through Peripheral Compared to Central Venous Catheters in a Rural Kenyan Hospital: Protocol for a Prospective, Observational Cohort Study (Preprint)

Grace Hezi Gao iD, Brian Kimani iD, Linette Lepore iD, Zahra Aghababa iD, Hannah Gitura iD, Michael Kinuthia iD, Jack Musau iD, Judy Muthoki iD, Alice Mwonge iD, Fredrick Ndibaru iD, Ann Viola Ndubi iD, Juliah Ndungu iD and 8 more

JMIR Research Protocols · 2025

DOI: 10.2196/81794 ↗

At a glance

Beobachtungsstudie in JMIR Research Protocols, 2025. Written by Grace Hezi Gao and 19 co-authors. Institution: Department of Critical Care Medicine, University of Pittsburgh Medical Center, 3520 Fifth Ave., Suite 100, Pittsburgh, PA, 15213, United States, 1 51…. Major MEDLINE topics: Vasoconstrictor Agents, Catheterization, Peripheral, Central Venous Catheters. 10 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

The infusion of vasopressors is a standard treatment for shock, and international guidelines recommend administering these medications through central venous catheters (CVCs) due to concerns about potential extravasation and local tissue injury with peripheral intravenous (PIV) administration. However, CVCs are often unavailable in resource-variable settings due to lack of human and material resources. Previous studies have assessed the safety of vasopressor infusion through PIV catheters but have considered only limited patient populations or a short infusion time or have used retrospective designs that may have failed to capture mild complications.

Objective

The primary objective of this study is to observe and describe the incidence of complications among patients receiving vasopressor infusion via PIV administration. The secondary objective is to assess whether the safety of PIV vasopressor administration is noninferior to the safety of administration via CVC.

Methods

This prospective observational study is being conducted at African Inland Church (AIC) Kijabe Hospital, a 360-bed tertiary care teaching hospital in rural Kenya. All patients (adult, obstetric, and pediatric) receiving intravenous vasopressor infusions who are admitted to the intensive care unit or high-dependency unit will be included. Patients will be followed up on twice daily from the start of vasopressor infusion to 72 hours after vasopressor discontinuation or death, whichever occurs first. Demographic, physiological, laboratory, therapeutic, and outcome data will be collected.

Results

Consecutive enrollment began in October 2023 and is ongoing. As of July 2025, we have enrolled 190 patients. We anticipate that the time to enroll the number of patients required to reach our power goal will be 24 months.

Conclusions

This study in a resource-variable setting will allow for more accurate and comprehensive data collection on vasopressor administration and potential complications as they arise, whereas most previous studies have been retrospective in nature. In addition, this is the first study of its kind to include both adult and pediatric patients within a mixed intensive care unit population with broad etiologies of shock, which could improve generalizability.

Subjects

MeSH terms (MEDLINE)

Vasoconstrictor AgentsCatheterization, PeripheralCentral Venous CathetersHumansProspective StudiesKenyaHospitals, RuralShockFemaleAdult

Author keywords

critical careglobal healthintensive carelimited resourcesshockvasopressors

Substances

Vasoconstrictor Agents

Authors and institutions

  • Department of Critical Care Medicine, University of Pittsburgh Medical Center, 3520 Fifth Ave., Suite 100, Pittsburgh, PA, 15213, United States, 1 512-810-1084.
  • Department of Medicine, AIC Kijabe Hospital, Kijabe, Kenya.
  • Department of Critical Care Medicine, Center for Research, Investigation, and Systems Modeling of Acute Illness (CRISMA), University of Pittsburgh, Pittsburgh, PA, United States.
  • Department of Pediatrics, AIC Kijabe Hospital, Kijabe, Kenya.
  • Department of Research, AIC Kijabe Hospital, Kijabe, Kenya.
  • Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

ORCID profiles: Grace Hezi Gao, Brian Kimani, Linette Lepore, Zahra Aghababa, Hannah Gitura, Michael Kinuthia, Jack Musau, Judy Muthoki, Alice Mwonge, Fredrick Ndibaru, Ann Viola Ndubi, Juliah Ndungu, Kinzi Nixon, Moses Odhiambo, Winslet Okari, Benjamin Thairu, Lilian Vihenda, Rachel M Wojcik, B Jason Brotherton, Kristina E Rudd

Cite

APA

Gao, G. H., Kimani, B., Lepore, L., Aghababa, Z., Gitura, H., Kinuthia, M., Musau, J., Muthoki, J., Mwonge, A., Ndibaru, F., Ndubi, A. V., Ndungu, J., Nixon, K., Odhiambo, M., Okari, W., Thairu, B., Vihenda, L., Wojcik, R. M., Brotherton, B. J., & Rudd, K. E. (2025). Safety of Administration of Vasopressors Through Peripheral Compared to Central Venous Catheters in a Rural Kenyan Hospital: Protocol for a Prospective, Observational Cohort Study (Preprint). JMIR Research Protocols. https://doi.org/10.2196/81794

Vancouver

Gao GH, Kimani B, Lepore L, Aghababa Z, Gitura H, Kinuthia M, et al. Safety of Administration of Vasopressors Through Peripheral Compared to Central Venous Catheters in a Rural Kenyan Hospital: Protocol for a Prospective, Observational Cohort Study (Preprint). JMIR Research Protocols. 2025. doi:10.2196/81794

BibTeX
@article{Gao2025,
  author = {Gao, Grace Hezi and Kimani, Brian and Lepore, Linette and Aghababa, Zahra and Gitura, Hannah and Kinuthia, Michael and Musau, Jack and Muthoki, Judy and Mwonge, Alice and Ndibaru, Fredrick and Ndubi, Ann Viola and Ndungu, Juliah and Nixon, Kinzi and Odhiambo, Moses and Okari, Winslet and Thairu, Benjamin and Vihenda, Lilian and Wojcik, Rachel M and Brotherton, B Jason and Rudd, Kristina E},
  title = {Safety of Administration of Vasopressors Through Peripheral Compared to Central Venous Catheters in a Rural Kenyan Hospital: Protocol for a Prospective, Observational Cohort Study (Preprint)},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/81794}
}
Start for free →